Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06063083 · ClinicalTrials.gov registry record · NA
Tell Me More ("Dime Mas")
A NA study of HIV and Mental Health Issue, sponsored by University of Miami.
- Active
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06063083: Active NA study of HIV and Mental Health Issue, sponsored by University of Miami.
NCT06063083 is a NA study of HIV and Mental Health Issue that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 90 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06063083, a NA study of HIV and Mental Health Issue, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be used to develop a program to help Latino men who have sex with men obtain pre-exposure prophylaxis (PrEP), HIV testing, and behavioral health services. The project will then involve a pilot test of this program with a community partner.
Primary Outcome
This will be assessed using the PrEP cascade measure, which specified five "levels" of PrEP engagement (i.e., pre-contemplation, contemplation, preparation, action, and maintenance). We will evaluate this outcome as an ordered-categorical outcome.
Conditions Studied
Interventions
- BEHAVIORAL Tell Me More ("Dime Mas")
- BEHAVIORAL Peer Ambassador Stories [Listen Miami ("Oye Miami")]
- BEHAVIORAL Standard Community Outreach
Study Locations (1)
Florida
- University of Miami - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-01-12 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT06063083 still lists
NCT06063083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Tell Me More ("Dime Mas") is the first listed.
NCT06063083 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06063083 about?
NCT06063083 is a clinical study titled "Tell Me More ("Dime Mas")". This study will be used to develop a program to help Latino men who have sex with men obtain pre-exposure prophylaxis (PrEP), HIV testing, and behavioral health services. The project will then involve a pilot test of this program with a community partner.
What is the current status of trial NCT06063083?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-01-12. Estimated completion is 2026-04-30.
What conditions does trial NCT06063083 study?
This clinical trial studies the following conditions: HIV, Mental Health Issue.
What interventions are being tested in trial NCT06063083?
The interventions under investigation include: Tell Me More ("Dime Mas") (BEHAVIORAL), Peer Ambassador Stories [Listen Miami ("Oye Miami")] (BEHAVIORAL), Standard Community Outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT06063083?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06063083 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06063083's enrollment target sits among peer trials
90 165th of 303 higher than 136 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI